Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

Assessing Target Engagement for Terazosin in Parkinson's Disease (TZPD2)

Neurology Adult Subjects Male Subjects Female Subjects

Overview

Principal investigator

Nandakumar Narayanan

Neurology

View other research studies by Nandakumar Narayanan

Eligibility criteria

Parkinson's disease

For Referring Providers

Do you have a patient you think would be a good candidate for this trial? Learn more about enrolling your patient.

Contact the study coordinator

Heena Olalde

319-356-8326

heena-olalde@uiowa.edu

Enroll your patient

Details

IRB Number

202510685

NCT Number

NCT07464028

Study Status

Open

Currently Recruiting

Yes

Study Type

Interventional

Primary Purpose

BASIC_SCIENCE

Phase

PHASE2

Cancer Study

Compensation Available

Yes